I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bleakman, A
153
results:
Search for persons
X
Format
Online (153)
Mediatypes
Articles (Online) (124)
OpenAccess-fulltext (29)
Languages
english (148)
french (1)
Sorted by: Relevance
Sorted by: Year
?
1
P507 United States and European patient perspectives on the..:
Travis, S
;
Bleakman, A
;
Dubinsky, M
...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i637-i639 , 2023
Link:
https://doi.org/10.1093/..
?
2
fMRI Measures of Drug Modulation of CNS Activation by Noxio..:
Upadhyay, J
;
Anderson, J
;
Schwarz, A.J.
...
NeuroImage. 47 (2009) - p. S62 , 2009
Link:
https://doi.org/10.1016/..
?
3
De Novo CNS Activation following Infusion of Fosaprepitant ..:
Upadhyay, J
;
Anderson, J
;
Schwarz, A.J.
...
NeuroImage. 47 (2009) - p. S61 , 2009
Link:
https://doi.org/10.1016/..
?
4
LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and..:
Sang, CN
;
Ramadan, NM
;
Wallihan, RG
...
Cephalalgia. 24 (2004) 7 - p. 596-602 , 2004
Link:
https://doi.org/10.1111/..
?
5
Pharmacological characterization of glutamatergic agonists ..:
Alt, A.
;
Weiss, B.
;
Ogden, A.M.
...
Neuropharmacology. 46 (2004) 6 - p. 793-806 , 2004
Link:
https://doi.org/10.1016/..
?
6
The AMPA Receptor Potentiator, LY404187 Modulates Expressio..:
O'Neill, M. J.
;
Mackowiak, M.
;
Lakics, V.
...
CNS Drug Reviews. 10 (2004) 2 - p. 193-193 , 2004
Link:
https://doi.org/10.1111/..
?
7
Novel AMPA receptor potentiators LY392098 and LY404187: eff..:
Miu, P
;
Jarvie, K.R
;
Radhakrishnan, V
...
Neuropharmacology. 40 (2001) 8 - p. 976-983 , 2001
Link:
https://doi.org/10.1016/..
?
8
Pharmacological effects of AMPA receptor potentiators LY392..:
Gates, M
;
Ogden, A
;
Bleakman, D
Neuropharmacology. 40 (2001) 8 - p. 984-991 , 2001
Link:
https://doi.org/10.1016/..
?
9
Kainate receptor pharmacology and physiology:
Bleakman, D.
Cellular and Molecular Life Sciences (CMLS). 56 (1999) 7-8 - p. 558-566 , 1999
Link:
https://doi.org/10.1007/..
?
10
Electrophysiological characterisation of the human N-type C..:
McNaughton, N.C.L.
;
White, C.
;
Clark, B.
...
Neuropharmacology. 38 (1999) 1 - p. 19-38 , 1999
Link:
https://doi.org/10.1016/..
?
11
LY339434, a GluR5 kainate receptor agonist:
Small, B
;
Thomas, J
;
Kemp, M
...
Neuropharmacology. 37 (1998) 10-11 - p. 1261-1267 , 1998
Link:
https://doi.org/10.1016/..
?
12
Electrophysiological characterisation of the human N-type C..:
McNaughton, N.C.L
;
Bleakman, D
;
Randall, A.D
Neuropharmacology. 37 (1998) 1 - p. 67-81 , 1998
Link:
https://doi.org/10.1016/..
?
13
The GluR5 subtype of kainate receptor regulates excitatory ..:
Vignes, M
;
Clarke, V.R.J
;
Parry, M.J
...
Neuropharmacology. 37 (1998) 10-11 - p. 1269-1277 , 1998
Link:
https://doi.org/10.1016/..
?
14
LY354740 is a Potent and Highly Selective Group II Metabotr..:
SCHOEPP, D.D
;
JOHNSON, B.G
;
WRIGHT, R.A
...
Neuropharmacology. 36 (1997) 1 - p. 1-11 , 1997
Link:
https://doi.org/10.1016/..
?
15
The synaptic activation of the GluR5 subtype of kainate rec..:
Vignes, M.
;
Bleakman, D.
;
Lodge, D.
.
Neuropharmacology. 36 (1997) 11-12 - p. 1477-1481 , 1997
Link:
https://doi.org/10.1016/..
1-15